arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

DarioHealth Corp.

DRIO
$2.69 ▼ -0.30 (-10.03%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
15 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

DarioHealth Corp. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $10.7M
Dividend Yield —
Revenue Growth -17.3% ↘
Op. Margin -163.9% ↗
ROIC -37.2% ↗
FCF / Share $-6.55 ↗
Trailing P/E 0.3x
Price / Book 0.3x
FCF Yield —
Debt / Equity 0.45
info Valuation on last close. End-of-day price, Nov 5, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$22.36M
↓ -17.3% —
Net Income Profit after all expenses
$-41.71M
↑ +2.4% —
Operating Margin Operating profit as % of sales
-163.9%
↑ +23.2% 1th
FCF / Share Free cash flow per share
$-6.55
↑ +58.5% —
Long-Term Debt Long-term obligations
$30.75M
↑ +31.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
1
Returns ↑
14
Financial Health ↑
42
Cash Quality ↓
45

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 15 years · 62 quarters